Brief: PLx Pharma Issues Statement On Recent USPTF Recommendations On Aspirin Therapy For Primary Prevention Of Cardiovascular Disease
14/10/2021 18:52
Oct 14 (Reuters) - PLx Pharma Inc PLXP.O :
* PLX PHARMA - ISSUED STATEMENT ON RECENT USPTF
RECOMMENDATIONS ON
ASPIRIN THERAPY FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE
Source text for Eikon: urn:newsml:reuters.com:*:nGNX1lTR6b
Further company coverage: PLXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PLx Pharma Winddown
See all newsAustralia's Pilbara Minerals jumps on Pilgangoora lithium resource upgrade
Brief: Plx Pharma Winddown Terminated Employment Of Natasha Giordano, President And CEO, And Rita O'connor, CFO
Brief: PLx Pharma Inc. Enters Into A Stalking Horse Asset Purchase Agreement To Sell Vazalore And Substantially All Of Its Assets
U.S. STOCKS ON THE MOVE-HeartCore, Freight Technologies, MongoDB
Brief: Plx Pharma Inc. Receives Nasdaq Delisting Notice